Detalhe da pesquisa
1.
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
Blood
; 136(2): 199-209, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325491
2.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Blood
; 127(15): 1896-906, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755711
3.
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
Curr Osteoporos Rep
; 15(5): 499-506, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889371
4.
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma.
Blood
; 123(26): 4120-31, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711662
5.
Pyk2 promotes tumor progression in multiple myeloma.
Blood
; 124(17): 2675-86, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25217697
6.
Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.
Haematologica
; 105(9): e470-473, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054066
7.
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.
Blood
; 119(6): 1468-78, 2012 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096244
8.
LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.
Blood
; 120(8): 1678-86, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22797699
9.
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.
Blood
; 119(24): 5782-94, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22394600
10.
Defining the role of TORC1/2 in multiple myeloma.
Blood
; 118(26): 6860-70, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045983
11.
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
Blood
; 116(9): 1506-14, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519629
12.
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia.
Blood
; 115(20): 4051-60, 2010 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110419
13.
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.
Blood
; 115(3): 559-69, 2010 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965685
14.
Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.
Ann Hematol
; 91(2): 257-69, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21720745
15.
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.
Lancet Oncol
; 12(3): 263-72, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21345726
16.
Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks.
Blood
; 113(16): 3781-91, 2009 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19020308
17.
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
Haematologica
; 96(5): 687-95, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21330323
18.
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.
Cancers (Basel)
; 13(11)2021 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067236
19.
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.
Haematologica
; 95(5): 794-803, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19951978
20.
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.
Leukemia
; 34(2): 589-603, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595039